Vlems F A, Diepstra J H S, Cornelissen I M H A, Ligtenberg M J L, Wobbes Th, Punt C J A, van Krieken J H J M, Ruers T J M, van Muijen G N P
Departments of Surgery, Pathology, University Medical Center, Nijmegen, PO Box 9101, 6500 HB Nijmegen, The Netherlands.
Anticancer Res. 2003 Jan-Feb;23(1A):179-86.
In order to develop a multi-marker RT-PCR, which as such may be more sensitive than a single marker assay for the detection of disseminated tumor cells, we evaluated six RT-PCR markers: cytokeratin 20 (CK20), carcinoembryonic antigen (CEA), guanylyl cyclase C (GCC), epidermal growth factor receptor (EGFR), matrilysin (MMP-7) and HeLa metastatic gene (HLM).
The expression was studied in human colon tumor cell lines, in colon cancer tissues, and in blood and/or bone marrow samples of colorectal cancer patients and control subjects.
The cell lines showed a differential expression pattern. The expression of all markers was detected in control blood samples with the lowest frequency for CK20 and EGFR. Semiquantitative analysis, which was performed to study threshold setting, demonstrated that GCC expression was elevated in patient compared to control samples. However, the reproducibility was questionable.
The results presented in this study suggest an enhanced sensitivity for a combination of RT-PCR markers. Due to limited specificity however, the development of a multi-marker RT-PCR by using conventional PCR does not seem feasible. Future studies should focus on the potential of quantitative RT-PCR.
为了开发一种多标志物逆转录聚合酶链反应(RT-PCR),其在检测播散性肿瘤细胞方面可能比单一标志物检测更敏感,我们评估了六种RT-PCR标志物:细胞角蛋白20(CK20)、癌胚抗原(CEA)、鸟苷酸环化酶C(GCC)、表皮生长因子受体(EGFR)、基质溶素(MMP-7)和HeLa转移基因(HLM)。
研究了这些标志物在人结肠肿瘤细胞系、结肠癌组织以及结直肠癌患者和对照受试者的血液和/或骨髓样本中的表达情况。
细胞系呈现出不同的表达模式。在对照血液样本中检测到所有标志物的表达,其中CK20和EGFR的表达频率最低。为研究阈值设定而进行的半定量分析表明,与对照样本相比,患者样本中GCC的表达升高。然而,其可重复性存在疑问。
本研究结果表明RT-PCR标志物组合具有更高的敏感性。然而,由于特异性有限,使用传统PCR开发多标志物RT-PCR似乎不可行。未来的研究应聚焦于定量RT-PCR的潜力。